CytomX Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
CytomX Therapeutics, Inc. has filed 794 SEC EDGAR filings since 28 Sep 2010

SEC filing history

Showing 201-225 of 794 matching filings.

Per page
25
Current page
9
UPLOAD

UPLOAD filing

Filing date
22 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-489946

D filing

Filing date
17 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-274010

S-3

Filing date
16 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Jul 2023
Reporting date
19 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
20 Jul 2023
Reporting date
19 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jun 2023
Reporting date
14 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jun 2023
Reporting date
14 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jun 2023
Reporting date
14 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jun 2023
Reporting date
14 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jun 2023
Reporting date
14 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jun 2023
Reporting date
14 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 May 2023
Reporting date
19 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37587

DEFA14A

Filing date
27 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37587

DEF 14A

Filing date
27 Apr 2023
Reporting date
14 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Mar 2023
Reporting date
29 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Mar 2023
Reporting date
22 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
29 Mar 2023
Reporting date
22 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-270869

S-8

Filing date
27 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .